In summary, the current data showed that MCS rescues DM-EPCD by reducing the levels of ROS, increasing the levels of NO, reducing the inflammation, enhancing the angiogenic properties, and restoring the expression of the CXCR4-SDF1α-VEGFR2 axis in D-EPCs. This evidence concerns the gene CXCL12 and diabetes mellitus.